AMC Stock Forecast, How High Could It Go in 2025 and Beyond?
AMC Entertainment (NYSE:AMC) has been rising lately after years of…
Sell
20
VATE Quote, Financials, Valuation and Earnings
Last price:
$5.37
Seasonality move
:
-11.75%
Day range:
$5.25 - $5.40
52-week range:
$3.25 - $13.79
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.07x
P/B ratio:
--
Volume:
7.5K
Avg. volume:
39K
1-year change:
-11.64%
Market cap:
$71.2M
Revenue:
$1.1B
EPS (TTM):
-$3.36
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Innovate has 832.84% upside to fair value with a price target of -- per share.
VATE vs. S&P 500
-
Over the past 5 trading days, Innovate has underperformed the S&P 500 by -6.3% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Innovate does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Innovate revenues have been falling on a year-over-year basis for 9 quarters in a row. In the most recent quarter Innovate reported revenues of $274.2M.
Earnings Growth
-
Innovate has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Innovate reported earnings per share of -$1.89.
Enterprise value:
720.5M
EV / Invested capital:
1.51x
Price / LTM sales:
0.07x
EV / EBIT:
17.07x
EV / Revenue:
0.68x
PEG ratio (5yr expected):
-0.09x
EV / Free cash flow:
313.26x
Price / Operating cash flow:
31.17x
Enterprise value / EBITDA:
9.66x
Gross Profit (TTM):
$205.7M
Return On Assets:
-4.64%
Net Income Margin (TTM):
-3.91%
Return On Equity:
--
Return On Invested Capital:
-8.03%
Operating Margin:
1.24%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $1.5B | $1.4B | $1.1B | $315.2M | $274.2M | |
| Gross Profit | $215.2M | $221M | $205.7M | $48.6M | $45.5M | |
| Operating Income | $8.7M | $33.3M | $40.6M | $2.8M | $3.4M | |
| EBITDA | $61.1M | $59.9M | $74.6M | $8.8M | $9.4M | |
| Diluted EPS | -$4.87 | -$5.66 | -$3.36 | -$2.21 | -$1.89 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $5.9B | $476.6M | $487.9M | $429.2M | $372.1M | |
| Total Assets | $6.4B | $1.1B | $1B | $943.5M | $868M | |
| Current Liabilities | $5.5B | $441.5M | $374.5M | $349M | $847.6M | |
| Total Liabilities | $6B | $1.1B | $1.2B | $1.1B | $1.1B | |
| Total Equity | $413.5M | -$21.6M | -$123.3M | -$174.4M | -$185M | |
| Total Debt | $546.1M | $681.1M | $697.2M | $675.7M | $663.4M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$23.1M | $78.1M | $20.4M | -$25.4M | -$14.1M | |
| Cash From Investing | $36.1M | -$15.4M | -$14.5M | -$3.3M | -$3.9M | |
| Cash From Financing | -$21.1M | -$40.2M | -$11.2M | -$12.9M | $2.4M | |
| Free Cash Flow | -$42.9M | $57.8M | $2.3M | -$31M | -$18.8M | |
VATE
Sector
Market Cap
$71.2M
$611.3M
Price % of 52-Week High
38.87%
77.95%
Dividend Yield
0%
0%
Shareholder Yield
--
2.29%
1-Year Price Total Return
-13.1%
-0.69%
Beta (5-Year)
1.782
0.775
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
-2.88%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$5.50
200-day SMA
Sell
Level
$6.42
Bollinger Bands (100)
Sell
Level
5.54 - 10.26
Chaikin Money Flow
Buy
Level
673.6K
20-day SMA
Sell
Level
$5.85
Relative Strength Index (RSI14)
Sell
Level
40.39
ADX Line
Sell
Level
10.58
Williams %R
Buy
Level
-93.9914
50-day SMA
Sell
Level
$6.06
MACD (12, 26)
Sell
Level
-0.28
25-day Aroon Oscillator
Sell
Level
-16
On Balance Volume
Neutral
Level
69.5M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.4878)
Sell
CA Score
(Annual)
Level (-2.9405)
Sell
Beneish M-Score
(Annual)
Level (-1.888)
Buy
Momentum Score
Level (4)
Sell
Ohlson Score
Level (5.1429)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (5)
Sell
Fundamental Score
Level (0)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.
Stock Forecast FAQ
In the current month, VATE has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The VATE average analyst price target in the past 3 months is --.
-
Where Will Innovate Stock Be In 1 Year?
According to analysts, the consensus estimate is that Innovate share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Innovate?
Analysts are divided on their view about Innovate share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Innovate is a Sell and believe this share price will drop from its current level to --.
-
What Is Innovate's Price Target?
The price target for Innovate over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is VATE A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Innovate is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of VATE?
You can purchase shares of Innovate via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Innovate shares.
-
What Is The Innovate Share Price Today?
Innovate was last trading at $5.37 per share. This represents the most recent stock quote for Innovate. Yesterday, Innovate closed at $5.30 per share.
-
How To Buy Innovate Stock Online?
In order to purchase Innovate stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Reddit Stock Be In 5 Years?
On a wet March morning last year, the famously orange…
Will Palantir Crash?
AI and data analytics software major Palantir (NASDAQ:PLTR) has been…
Stock Ideas
Buy
65
Is MSFT Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 41x
Buy
59
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 49x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Alerts
Sell
47
RGC alert for Jun 18
Regencell Bioscience Holdings [RGC] is down 18.36% over the past day.
Sell
20
ENPH alert for Jun 18
Enphase Energy [ENPH] is up 4.18% over the past day.
Sell
49
QNTM alert for Jun 18
Quantum BioPharma [QNTM] is up 17.61% over the past day.
